Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Nuvectis Pharma Inc (NVCT)

60 + Investors. Track Smart Money conviction in NVCT. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +12
Streak
1Q ▲
Buyers last Q
74%

Smart Money Signals — NVCT

Based on 61 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds added NVCT than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
61 hedge funds hold NVCT right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +79% more funds vs a year ago

fund count last 6Q
+27 new funds entered over the past year (+79% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟢

More buyers than sellers — 74% buying

37 buying13 selling
Last quarter: 37 funds were net buyers (16 opened a brand new position + 21 added to an existing one). Only 13 were sellers (9 trimmed + 4 sold completely). A clear majority buying is a strong confirmation signal.
📈

More new buyers each quarter (+12 vs last Q)

new funds entering per quarter
Funds opening a new NVCT position: 20 → 11 → 4 → 16. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
📌

Mixed — 33% long-term, 34% new

■ 33% conviction (2yr+) ■ 33% medium ■ 34% new
Of the 61 current holders: 20 (33%) held >2 years, 20 held 1–2 years, and 21 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.
📊

Peak discovery — momentum slowing

10 → 20 → 11 → 4 → 16 new funds/Q
New funds entering each quarter: 20 → 11 → 4 → 16. NVCT is well-known in the hedge fund world, but fresh entries are gradually declining. The explosive phase of institutional discovery is likely behind us.
🏛️

Veteran-anchored — 43% veterans vs 39% newcomers

■ 43% veterans ■ 18% 1-2yr ■ 39% new
Entry-cohort mix of 61 holders: 26 (43%) are 2+ year veterans, 11 entered 1–2 years ago, and 24 (39%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
✅

Strong quality — 24% AUM from major funds

24% from top-100 AUM funds
22 of 60 holders rank in the top 100 by AUM, accounting for 24% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
4.3
out of 10
Moderate Exit Risk
Exit risk score 4.3/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — NVCT

In 2026 Q1, 37 hedge funds were net buyers of NVCT (16 opened a new position, 21 added to an existing one), while 13 reduced or exited (9 trimmed, 4 sold completely) — a 74% buyer ratio, indicating clear institutional accumulation. 24% of total institutional value in NVCT is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: +12 funds (more new holders than closures). Total institutional holders: 61.

Hedge Fund Ownership: NVCT

How many hedge funds hold NVCT — quarterly history vs. share price
Quarterly hedge fund ownership of NVCT vs. share price

Market Analysis: NVCT

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: NVCT

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Nuvectis Pharma Inc (NVCT) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much NVCT has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 83d ago
NVCT
+78.8%
XLV
+705.0%

NVCT outperformed XLV by -626.2% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 38d ago
NVCT
+25.2%
XLV
+691.9%

Since the filing became public, NVCT outperformed XLV by -666.7% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

11 top-rated funds 0 high-conviction
Consensus
4.7
/ 10
breadth
×
Elite
0.6
/ 10
conviction
Hedge Fund Positioning: NVCT
60 + Investors

Track Smart Money conviction in NVCT. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 60 49 22.45%
13F Shares 5M 4M 2.73%
Total Value $35M $33M 5.27%
New Positions 15 4 +11
Increased Positions 19 27 -8
Closed Positions 4 8 -4
Reduced Positions 10 8 +2
Total Calls 1 2 -50.0%
Total Puts 0 2 -100.0%
PUT/CALL Ratio 0.0 1.0 Bullish

Statistics: NVCT

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

60 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in NVCT. Verified SEC 13F-HR filings.

QUARTER:
Top 25 NVCT holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Iridian Asset Management LLC/Ct 2.04% 651,757 $5.0M
2 Occam Crest Management LP 1.91% 407,147 $3.1M
3 Baldwin Wealth Partners LLC/Ma 0.21% 378,625 $2.9M
4 Forbes J M & Co LLP 0.04% 59,000 $456K
5 Austin Wealth Management, LLC 0.03% 20,125 $154K
6 Avalon Trust Co 0.01% 14,000 $108K
7 Oppenheimer & Co Inc 0.01% 73,566 $569K
8 Nations Financial Group Inc, /Ia/ /Adv 0.01% 13,000 $100K
9 Martingale Asset Management L P 0.00% 18,024 $139K
10 Nbc Securities, INC. 0.00% 3,000 $23K
11 Edmond de Rothschild Holding S.A. 0.00% 15,170 $117K
12 XTX Topco Ltd 0.00% 10,066 $78K
13 Tower Research Capital LLC (TRC) 0.00% 5,762 $45K
14 Ameritas Investment Partners, Inc. 0.00% 1,314 $10K
15 CIBC Bancorp USA Inc. 0.00% 25,662 $198K
16 Police & Firemen's Retirement System of New Jersey 0.00% 3,785 $29K
17 GAMMA Investing LLC 0.00% 645 $5K
18 Vanguard Fiduciary Trust Co 0.00% 114,842 $888K
19 Marshall Wace, LLP 0.00% 29,223 $226K
20 Vanguard Capital Management LLC 0.00% 659,879 $5.1M
21 BlackRock, Inc. 0.00% 764,441 $5.9M
22 Citadel Advisors LLC 0.00% 78,425 $606K
23 Susquehanna International Group, LLP 0.00% 105,286 $814K
24 Spire Wealth Management 0.00% 300 $2K
25 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. 0.00% 7,368 $57K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Nuvectis Pharma Inc (NVCT)

What does the Smart Money Trend signal show for NVCT?

Buying streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds added NVCT than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for NVCT?

More buyers than sellers — 74% buying: Last quarter: 37 funds were net buyers (16 opened a brand new position + 21 added to an existing one). Only 13 were sellers (9 trimmed + 4 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for NVCT holders?

Strong quality — 24% AUM from major funds: 22 of 60 holders rank in the top 100 by AUM, accounting for 24% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held NVCT?

Mixed — 33% long-term, 34% new: Of the 61 current holders: 20 (33%) held >2 years, 20 held 1–2 years, and 21 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Is it too late to buy Nuvectis Pharma Inc (NVCT) following the 2026 Q1 hedge fund 13F filings?

As of today, NVCT has moved +25.2% since the 2026 Q1 13F filing date (May 15, 2026), compared to +691.9% for the XLV sector ETF — an outperformance of -666.7%. Since the quarter end (March 31, 2026), NVCT has gained +78.8% vs +705.0% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →